Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Admiral H1 profits surge to record high amid UK customer growth

(Sharecast News) - Insurance firm Admiral Group delivered a robust set of interim results on Thursday, with growth in customer numbers and a continued focus on pricing discipline helping to offset sector-wide pressures. Admiral said pre-tax profits from continuing operations jumped 69% to £521.0m, driven by standout performances in UK Motor, Household, and Admiral Money, with insurance revenue rising 18% to £2.47bn and gross loan balances at Admiral Money climbing 25% to £1.28bn.

The Cardiff-based insurer highlighted that margins had benefited from falling car insurance prices in the UK across the six months ended 30 June, with its profits in its motor division increasing by 56%.

Admiral also said customer growth remained a key highlight in the half, with total group customers up 10% to 11.42m, as a 13% increase in UK insurance customers offset a 3% in European customers.

CEO Milena Mondini de Focatiis said: "We have delivered another excellent first half with strong execution across all strategic objectives. Group profit increased 69% to a record £521m.

"I'm very excited to see our businesses go from strength to strength. I'm confident in our fundamentals and adaptability which mean that we are well-placed for further success, delivering even more value for our shareholders and our growing customer base."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.